Analysis of US FDA-Approved Drugs Containing Sulfur Atoms

被引:884
作者
Scott, Kevin A. [1 ,2 ]
Njardarson, Jon T. [1 ]
机构
[1] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA
[2] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
基金
美国国家科学基金会;
关键词
Sulfonamide; Thioether; Sulfoxide; Sulfone; Sulfate; Sulfur heterocycle; P2Y(12) RECEPTOR; MANAGEMENT; DOPAMINE; MECHANISMS; CHEMISTRY; PROTEASE; DISEASE; ANALOGS; FAMILY;
D O I
10.1007/s41061-018-0184-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this review, we discuss all sulfur-containing FDA-approved drugs and their structures. The second section of the review is dedicated to structural analysis and is divided into 14 subsections, each focusing on one type of sulfur-containing moiety. A concise graphical representation of each class features drugs that are organized on the basis of structural similarity, evolutionary relevance, and medical indication. This review offers a unique and comprehensive overview of the structural features of all sulfur-containing FDA-approved drugs to date.
引用
收藏
页数:34
相关论文
共 67 条
[1]   STRUCTURE OF CEPHALOSPORIN C [J].
ABRAHAM, EP ;
NEWTON, GGF .
BIOCHEMICAL JOURNAL, 1961, 79 (02) :377-&
[2]   Putting chirality to work: The strategy of chiral switches [J].
Agranat, I ;
Caner, H ;
Caldwell, A .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (10) :753-768
[3]   Stereoselective disposition of proton pump inhibitors [J].
Andersson, Tommy ;
Weidolf, Lars .
CLINICAL DRUG INVESTIGATION, 2008, 28 (05) :263-279
[4]   TOTAL SYNTHESIS OF BLEOMYCIN [J].
AOYAGI, Y ;
KATANO, K ;
SUGUNA, H ;
PRIMEAU, J ;
CHANG, LH ;
HECHT, SM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1982, 104 (20) :5537-5538
[5]   Emtricitabine - An antiretroviral agent for HIV infection [J].
Bang, LM ;
Scott, LJ .
DRUGS, 2003, 63 (22) :2413-2424
[6]   Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents [J].
Besancon, M ;
Simon, A ;
Sachs, G ;
Shin, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (36) :22438-22446
[7]   Promiscuous modulation of ion channels by anti-psychotic and anti-dementia medications [J].
Bianchi, Matt T. .
MEDICAL HYPOTHESES, 2010, 74 (02) :297-300
[8]  
BIEDER A, 1966, ANN PHARM FR, V24, P493
[9]   Rationale for use of dopamine agonists in Parkinson's disease: Review of ergot derivatives [J].
Blanchet, PJ .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 :S21-S26
[10]   CLINICAL TRIALS WITH BLEOMYCIN IN LYMPHOMAS AND IN SOLID TUMORS [J].
BONADONNA, G ;
BAJETTA, E ;
BARTOLI, C ;
BERETTA, G ;
DELENA, M ;
MONFARDINI, S ;
FOSSATIB.F .
EUROPEAN JOURNAL OF CANCER, 1972, 8 (02) :205-+